Back
Corporate News
Orchid Pharma continues to be under rating watch with developing implications
07-Mar-2025, 01:33
Orchid Pharma announced that CARE has continued the rating CARE A-/ CARE A2 while maintaining a rating watch with developing implications for bank facilities availed by the company.
Orchid Pharma announced that CARE has continued the rating CARE A-/ CARE A2 while maintaining a rating watch with developing implications for bank facilities availed by the company.
Powered by Capital Market - Live News